Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17

BACKGROUND: Health-related quality of life (HRQoL) has become a major endpoint to assess the clinical benefit of new therapeutic strategies in oncology clinical trials. Typically, HRQoL outcomes are analyzed using linear mixed models (LMMs). However, longitudinal analysis of HRQoL in the presence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuer, B., Mollevi, C., Anota, A., Charton, E., Juzyna, B., Conroy, T., Touraine, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469318/
https://www.ncbi.nlm.nih.gov/pubmed/32883216
http://dx.doi.org/10.1186/s12874-020-01104-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469318/
https://www.ncbi.nlm.nih.gov/pubmed/32883216
http://dx.doi.org/10.1186/s12874-020-01104-w

Ejemplares similares